Observational studyJournal for immunotherapy of cancer2024

Reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase.

Roberta Noseda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.